TP53 was mutated in 24% (n=421) of the invasive breast cancer cohort from The Cancer Genome Atlas (TCGA), 23% (n=251) from GSE3494 and 36% (n=61) from GSE61725 (Supplementary Figure 1A). The gene discussed is TP53; the disease is invasive breast carcinoma.